(VIANEWS) – Vertex (VERX), ANSYS (ANSS), iRadimed Corporation (IRMD) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Vertex (VERX)
12.4% sales growth and 8.62% return on equity
Vertex, Inc. provides tax technology solutions for corporations in retail, leasing, communication, and manufacturing industries in the United States and internationally. It offers tax determination, compliance and reporting, tax data management, document management, pre-built integration, and industry-specific solutions. The company sells its software products through software license and software as a service subscriptions. It also offers implementation and training services in connection with its software license and cloud subscriptions, transaction tax returns outsourcing, and other tax-related services. The company was founded in 1978 and is headquartered in King of Prussia, Pennsylvania.
Earnings Per Share
As for profitability, Vertex has a trailing twelve months EPS of $0.13.
PE Ratio
Vertex has a trailing twelve months price to earnings ratio of 276.08. Meaning, the purchaser of the share is investing $276.08 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.62%.
Sales Growth
Vertex’s sales growth is 14.3% for the ongoing quarter and 12.4% for the next.
Moving Average
Vertex’s worth is under its 50-day moving average of $36.88 and way above its 200-day moving average of $31.14.
Volume
Today’s last reported volume for Vertex is 13400 which is 98.54% below its average volume of 919924.
Yearly Top and Bottom Value
Vertex’s stock is valued at $35.89 at 16:22 EST, way under its 52-week high of $40.05 and way above its 52-week low of $20.48.
Previous days news about Vertex(VERX)
- Vertex stock loses around $3b in 3 months: buy the dip or steer clear?. According to Zacks on Wednesday, 11 September, "In CF, Vertex is evaluating its medicines in younger patient populations and aims to have small-molecule treatments for most people with the condition. ", "It can potentially treat CF patients who have discontinued Trikafta or other Vertex CF medicines. "
- According to Zacks on Thursday, 12 September, "The collaboration will combine the company’s expertise in optimizing the healthcare supply chain with Google Cloud’s Vertex AI platform, to tackle the modern supply chain management complexities and support the patients more effectively."
- According to Zacks on Friday, 13 September, "Google Cloud’s portfolio of products - including BigQuery, Vertex AI, and Looker - remains at the core of this transformation. "
2. ANSYS (ANSS)
11.4% sales growth and 9.43% return on equity
ANSYS, Inc. develops and markets engineering simulation software and services for engineers, designers, researchers, and students in the United States, Japan, Germany, China, Hong Kong, South Korea, rest of Europe, the Middle East, Africa, and internationally. It offers structural analysis product suite that provides simulation tools for product design and optimization; the Ansys Mechanical product, an element analysis software; LS-DYNA solver for multiphysics simulation; and power analysis and optimization software suite. The company also offers electronics product suite that provides electromagnetic field simulation software for designing electronic and electromechanical products; Ansys High Frequency Structure Simulator product for radio frequency and microwave design; SCADE product suite, a solution for embedded software simulation, code production, and automated certification; fluids product suite that enables modeling of fluid flow and other related physical phenomena; Ansys Fluent computational fluid dynamics software package; Ansys RedHawk-SC for electronic design automation; Ansys Optics software; and mission-simulation, modeling, testing, and analysis software. In addition, it offers Ansys Granta MI system for materials information management; Ansys Granta Selector technology for materials selection and graphical analysis; CES EduPack product, a set of teaching resources; Granta Materials Data for Simulation; Ansys Lumerical product, a photonics simulation software solution; safety-certified embedded software solutions; Discovery product family for use in the simulation of product design; academic product suite for research and teaching settings. ANSYS, Inc. was founded in 1970 and is headquartered in Canonsburg, Pennsylvania.
Earnings Per Share
As for profitability, ANSYS has a trailing twelve months EPS of $5.72.
PE Ratio
ANSYS has a trailing twelve months price to earnings ratio of 58.43. Meaning, the purchaser of the share is investing $58.43 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.43%.
Sales Growth
ANSYS’s sales growth is 12.7% for the present quarter and 11.4% for the next.
Volume
Today’s last reported volume for ANSYS is 629906 which is 6.91% below its average volume of 676686.
Revenue Growth
Year-on-year quarterly revenue growth grew by 19.6%, now sitting on 2.32B for the twelve trailing months.
Previous days news about ANSYS(ANSS)
- According to Zacks on Friday, 13 September, "Some better-ranked stocks worth consideration in the broader technology space are Manhattan Associates (MANH Quick QuoteMANH – Free Report) , Adobe (ADBE Quick QuoteADBE – Free Report) and ANSYS (ANSS Quick QuoteANSS – Free Report) . ", "While Manhattan Associates sports a Zacks Rank #1 (Strong Buy), Adobe and ANSYS carry a Zacks Rank #2 (Buy) each at present. "
- According to Zacks on Thursday, 12 September, "Some better-ranked stocks worth consideration in the broader technology space are Manhattan Associates (MANH Quick QuoteMANH – Free Report) , Adobe (ADBE Quick QuoteADBE – Free Report) and ANSYS (ANSS Quick QuoteANSS – Free Report) . ", "While Manhattan Associates sports a Zacks Rank #1 (Strong Buy), Adobe and ANSYS carry a Zacks Rank #2 (Buy) each at present. "
- According to Zacks on Thursday, 12 September, "However, Synopsys’ strong positioning in AI-driven semiconductor design and the potential boost from the pending ANSYS acquisition provide compelling reasons to hold on to the stock.", "Another major growth driver for Synopsys is its pending acquisition of ANSYS Inc. (ANSS Quick QuoteANSS – Free Report) , a leader in engineering simulation. "
- According to Zacks on Wednesday, 11 September, "Here we select four such companies - ANSYS Inc. (ANSS Quick QuoteANSS – Free Report) , Datadog Inc. (DDOG Quick QuoteDDOG – Free Report) , PROS Holdings Inc. (PRO Quick QuotePRO – Free Report) and Varonis Systems Inc. (VRNS Quick QuoteVRNS – Free Report) ."
3. iRadimed Corporation (IRMD)
10.4% sales growth and 25.08% return on equity
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible patient vital signs monitoring system. The company also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. It serves hospitals, acute care facilities, and outpatient imaging centers. The company sells its products through direct field sales representatives, regional sales directors, clinical support representatives, and independent distributors. IRADIMED CORPORATION was incorporated in 1992 and is headquartered in Winter Springs, Florida.
Earnings Per Share
As for profitability, iRadimed Corporation has a trailing twelve months EPS of $1.46.
PE Ratio
iRadimed Corporation has a trailing twelve months price to earnings ratio of 32.16. Meaning, the purchaser of the share is investing $32.16 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 25.08%.
Yearly Top and Bottom Value
iRadimed Corporation’s stock is valued at $46.96 at 16:22 EST, below its 52-week high of $50.93 and way higher than its 52-week low of $36.12.
4. StealthGas (GASS)
8.1% sales growth and 9.6% return on equity
StealthGas Inc., together with its subsidiaries, provides seaborne transportation services to liquefied petroleum gas (LPG) producers and users internationally. It also provides crude oil and natural gas. The company's carriers carry various petroleum gas products in liquefied form, including propane, butane, butadiene, isopropane, propylene, and vinyl chloride monomer; and refined petroleum products, such as gasoline, diesel, fuel oil, and jet fuel, as well as edible oils and chemicals. As of December 31, 2021, it had a fleet of 44 LPG carriers with a total capacity of 389,426 cubic meters; three medium range product carriers with a total capacity of 140,000 deadweight tons (dwt); and one Aframax crude oil tanker with a total capacity of 115,804 dwt. StealthGas Inc. was incorporated in 2004 and is based in Athens, Greece.
Earnings Per Share
As for profitability, StealthGas has a trailing twelve months EPS of $1.42.
PE Ratio
StealthGas has a trailing twelve months price to earnings ratio of 4.2. Meaning, the purchaser of the share is investing $4.2 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.6%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 9.2%, now sitting on 147.03M for the twelve trailing months.
Volume
Today’s last reported volume for StealthGas is 63426 which is 51.02% below its average volume of 129506.
Moving Average
StealthGas’s value is below its 50-day moving average of $6.53 and way below its 200-day moving average of $6.67.
Yearly Top and Bottom Value
StealthGas’s stock is valued at $5.97 at 16:22 EST, way below its 52-week high of $8.84 and way above its 52-week low of $4.61.
5. EZCORP (EZPW)
7.7% sales growth and 10.15% return on equity
EZCORP, Inc. provides pawn services in the United States and Latin America. The company operates through three segments: U.S. Pawn, Latin America Pawn, and Other Investments. The company offers pawn loans collateralized by tangible personal property, jewelry, consumer electronics, tools, sporting goods, and musical instruments. It also retails merchandise, primarily collateral forfeited from pawn lending operations and pre-owned merchandise purchased from customers. In addition, the company provides EZ+, a web-based application that allow customers to manage their pawn transactions, layaways, and loyalty rewards online. Further, it operates under the EZPAWN, Value Pawn & Jewelry, Empeño Fácil, Cash Apoyo Efectivo, GuatePrenda, and MaxiEfectivo brands. EZCORP, Inc. was incorporated in 1989 and is headquartered in Austin, Texas.
Earnings Per Share
As for profitability, EZCORP has a trailing twelve months EPS of $1.2.
PE Ratio
EZCORP has a trailing twelve months price to earnings ratio of 10.18. Meaning, the purchaser of the share is investing $10.18 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.15%.
Previous days news about EZCORP(EZPW)
- According to Zacks on Thursday, 12 September, "For those interested in the idea, two small-caps - Heritage Insurance (HRTG Quick QuoteHRTG – Free Report) and EZCORP (EZPW Quick QuoteEZPW – Free Report) - sport favorable growth profiles paired with positive Zacks Ranks. ", "And concerning those with bright outlooks, both stocks above Heritage Insurance (HRTG Quick QuoteHRTG – Free Report) and EZCORP (EZPW Quick QuoteEZPW – Free Report) - fit the criteria nicely, with each boasting positive growth expectations paired with favorable Zacks Ranks."
